Tvardi Therapeutics Inc (TVRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,176 | -58,144 | -26,665 | -85,474 | -55,135 |
| Depreciation Amortization | 1,239 | 821 | 339 | 1,934 | 1,740 |
| Accounts receivable | -1,277 | -6,788 | -2,805 | -3,301 | -9,619 |
| Other Working Capital | 208 | -4,535 | -11,645 | -12,924 | -15,758 |
| Other Operating Activity | 11,298 | 13,583 | 6,158 | 21,035 | 23,552 |
| Operating Cash Flow | $-74,708 | $-55,063 | $-34,618 | $-78,730 | $-55,220 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 73,989 | 50,511 | 17,708 | 128,750 | 84,327 |
| PPE Investments | -323 | N/A | N/A | -43 | -43 |
| Investing Cash Flow | $73,666 | $50,511 | $17,708 | $128,707 | $84,284 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,676 | 560 | 560 | 311 | 289 |
| Financing Cash Flow | $1,676 | $560 | $560 | $311 | $289 |
| Beginning Cash Position | 64,149 | 64,149 | 64,149 | 13,861 | 13,861 |
| End Cash Position | 64,783 | 60,157 | 47,799 | 64,149 | 43,214 |
| Net Cash Flow | $634 | $-3,992 | $-16,350 | $50,288 | $29,353 |
| Free Cash Flow | |||||
| Operating Cash Flow | -74,708 | -55,063 | -34,618 | -78,730 | -55,220 |
| Capital Expenditure | -323 | N/A | N/A | -43 | -43 |
| Free Cash Flow | -75,031 | -55,063 | -34,618 | -78,773 | -55,263 |